We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×
Home > News > Science & Health > Content Piece

Cannabidiol Reduces Seizures in Children with Severe Epilepsy

Published: May 31, 2017   
Listen with
Speechify
0:00
Register for FREE to listen to this article
Thank you. Listen to this article using the player above.

Results from a double-blind, placebo-controlled trial published in The New England Journal of Medicine revealed that c hildren with Dravet syndrome, a severe form of epilepsy, had fewer seizures after taking a daily oral solution of the cannabis compound called cannabidiol, which does not have the psychoactive properties of marijuana. Over a 14-week treatment with cannabidiol, convulsive seizures dropped from a monthly average of 12.4 to 5.9. In comparison, seizures in the placebo group decreased from a monthly average of 14.9 to 14.1. During the study, seizures stopped completely in 5 percent of patients taking cannabidiol. 


“Seizures in Dravet syndrome are extremely difficult to control and they can be deadly,” says study co-author Linda Laux, MD, from Stanley Manne Children’s Research Institute at Ann & Robert H. Lurie Children’s Hospital of Chicago. “Our results are encouraging, especially considering that we don’t have any antiepileptic drugs approved for Dravet syndrome in the U.S.”


The study included 120 children and young adults with Dravet syndrome and drug-resistant seizures. They were randomly assigned to receive either cannabidiol or a placebo, in addition to standard antiepileptic treatment. 


Adverse events were reported in 93 percent of the patients taking cannabidiol, compared to 75 percent of the patients in the placebo group. The most common side effects were drowsiness, diarrhea and decreased appetite.


"We will need more data to determine the long-term efficacy and safety of cannabidiol for Dravet syndrome,” says Laux, who is the Medical Director of the Comprehensive Epilepsy Center at Lurie Children’s  and Assistant Professor of Pediatrics at Northwestern University Feinberg School of Medicine.


This article has been republished from materials provided by Ann & Robert H. Lurie Children's Hospital of Chicago. Note: material may have been edited for length and content. For further information, please contact the cited source.


Reference


Devinsky, O., Cross, J. H., Laux, L., Marsh, E., Miller, I., Nabbout, R., ... & Wright, S. (2017). Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. New England Journal of Medicine, 376(21), 2011-2020.

 

Like what you just read? You can find similar content on the topic tag shown below.

Science & Health

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter

 
Advertisement